Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-50
SponsorCairo University

About this trial

glaucoma is prevalent among obstructive sleep apnea (OSA). contnous passive airway pressure is main treatment of OSA. lifestyle corrections also recommended

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Obstructive sleep apnea patients

obese patients

glaucoma (open angle form with ocular hyoertension)

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • lifetyle corrections and CPAP

    Behavioral

    twenty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved in group I will apply CPAP during night sleeping daily for three month. group I will apply lifestyle corrections (low calories diet intake and 3-session per-week 40-minute treadmill walking for three month.

  • CPAP

    Other intervention

    twenty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved in group II will apply CPAP during night sleeping daily for three month.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: group number 1Experimental treatment 1 intervention
Group B: group number 2Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Intraocular pressure

it will be measured by tonometery

Time frame
it will be measured after 12 weeks

Secondary outcomes

1

apnea hypopnea index

it is an indicator on numbe rof apnea during sleep

Time frame
It will be measured after 12 weeks
2

Epowrth sleepiness scale

a questioanire assess rate of sleepiness

Time frame
It will be measured after 12 weeks
3

body mass index

it assesed on empty bladder and bowel

Time frame
It will be measured after 12 weeks
4

waist circumference

it will be assesed at umbilical level

Time frame
it will be measured after 12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.